Zobrazeno 1 - 10
of 77
pro vyhledávání: '"E. A. Shestakova"'
Autor:
M. V. Shestakova, G. R. Vagapova, O. K. Vikulova, G. R. Galstyan, T. Yu. Demidova, E. N. Dudinskaya, T. P. Kiseleva, A. M. Mkrtumyan, N. A. Petunina, O. N. Tkacheva, V. V. Fadeev, Y. S. Khalimov, E. A. Shestakova
Publikováno v:
Сахарный диабет, Vol 26, Iss 6, Pp 619-625 (2023)
TThe annual increase in the prevalence of type 2 diabetes mellitus emphasizes the relevance of the search for new treatment options, along with necessity for regular review of proven therapeutic solutions. Today, dipeptidyl peptidase-4 inhibitors (DP
Externí odkaz:
https://doaj.org/article/a9f62b279e3c4b2aa4fd5e55d9c3b6e3
Autor:
E. A. Shestakova, I. A. Sklyanik, A. S. Panevina, A. V. Yurasov, Yu. I. Yashkov, M. S. Sineokaya, A. O. Gavrilova, V. V. Evdoshenko, V. V. Fedenko, N. S. Bordan, M. V. Shestakova
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 446-454 (2023)
There are several models for predicting remission of type 2 diabetes mellitus (T2D) a year after bariatric surgery — DiaRem, ABSD, IMS, etc. However, these models cannot be used to predict the early normalization of glycemia (within a few months af
Externí odkaz:
https://doaj.org/article/3cd1928399ec497bb4297338bc492b2a
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 439-445 (2023)
BACKGROUND: One of the function of the endothelium is the maintenance of body's homeostasis. Endothelial dysfunction is known to be profoundly implicated in the pathogenesis of cardiovascular diseases (CVD). The presence of diabetes mellitus signific
Externí odkaz:
https://doaj.org/article/b0ac788307414c37b928496529b51d4b
Autor:
R. M. Guseinova, E. A. Shestakova
Publikováno v:
Ожирение и метаболизм, Vol 19, Iss 3, Pp 300-305 (2023)
Obesity and type 2 diabetes mellitus (T2DM) are major problems for public health all over the world. According to retrospective research, the prevalence of obesity has doubled in more than 70 countries since 1980, as well as the prevalence of obesity
Externí odkaz:
https://doaj.org/article/2d96c070fc864f038c85b4f864b8dd24
Feсal microbiota transplantation in the format of complex therapy in obesive siblings: clinical case
Autor:
E. V. Pokrovskaya, E. S. Zhgun, E. A. Shestakova, I. A. Sklyanik, I. V. Fedushkina, E. I. Olekhnovich, D. N. Konanov, D. A. Kardonsky, Yu. V. Kislun, E. A. Sorokina, L. I. Zilberman, N. V. Zaytseva, E. N. Ilina, V. M. Govorun, M. V. Shestakova
Publikováno v:
Сахарный диабет, Vol 25, Iss 4, Pp 405-417 (2022)
Obesity and associated metabolic diseases are often accompanied by changes in the gut microbiota leading to metagenome gene diversity decrease. Fecal microbiota transplantation (FMT) is one of the most effective methods for correcting the intestinal
Externí odkaz:
https://doaj.org/article/1921d8662c654e4ca3b0491ea026d1b9
Autor:
E. A. Shestakova
Publikováno v:
Успехи молекулярной онкологии, Vol 8, Iss 1, Pp 10-16 (2021)
Recently multiple data accumulated concerning mutations in the ESR1 gene coding estrogen receptor α (mutESR1) and in the LYN gene coding non receptor tyrosine kinase SRC family member (mutLYN) that are associated with endocrine therapy resistance an
Externí odkaz:
https://doaj.org/article/6843878dcf284dedb9cffd78f5c9e081
Autor:
I. I. Dedov, M. V. Shestakova, G. A. Melnichenko, N. V. Mazurina, E. N. Andreeva, I. Z. Bondarenko, Z. R. Gusova, F. K. Dzgoeva, M. S. Eliseev, E. V. Ershova, M. V. Zhuravleva, T. A. Zakharchuk, V. A. Isakov, M. V. Klepikova, K. A. Komshilova, V. S. Krysanova, S. V. Nedogoda, A. M. Novikova, O. D. Ostroumova, A. P. Pereverzev, R. V. Rozhivanov, T. I. Romantsova, L. A. Ruyatkina, A. S. Salasyuk, A. N. Sasunova, S. A. Smetanina, A. V. Starodubova, L. A. Suplotova, O. N. Tkacheva, E. A. Troshina, M. V. Khamoshina, S. M. Chechelnitskaya, E. A. Shestakova, E. V. Sheremet’eva
Publikováno v:
Ожирение и метаболизм, Vol 18, Iss 1, Pp 5-99 (2021)
Clinical guidelines have long been one of the working tools of the modern doctor, helping him quickly navigate the most effective proven methods of treatment and prevention of various diseases, and also to adapt these methods to the specific tasks of
Externí odkaz:
https://doaj.org/article/8965b370fe344220bcb7e593bcaaef2f
Publikováno v:
Сахарный диабет, Vol 23, Iss 6, Pp 541-547 (2021)
Concerning the uncontrolled growth in the incidence of obesity and Type 2 Diabetes Mellitus (T2DM), numerous research have been carried out to study the pathogenetic mechanisms of progress of these diseases and development of new methods for their pr
Externí odkaz:
https://doaj.org/article/b6feeae3f36e45df88a2fbba4d96c784
Publikováno v:
Ожирение и метаболизм, Vol 17, Iss 4, Pp 332-339 (2020)
Background: Obesity is one of the most significant risk factors for type 2 diabetes (T2D), but a large number of patients with morbid obesity maintain normal glycemia for a long time. There are no definite easy-to-measure clinical features that disti
Externí odkaz:
https://doaj.org/article/e363291cadc740f38a30ccc5d0db4b4d
Autor:
E. A. Shestakova, I. A. Sklyanik, A. S. Panevina, L. V. Nikankina, M. V. Shestakova, I. I. Dedov
Publikováno v:
Терапевтический архив, Vol 92, Iss 10, Pp 15-22 (2020)
Aim.Obese patients without diabetes present an interesting phenotype to explore protective mechanisms against type 2 diabetes (T2D) development. In our study we looked for specific hormonal features of obese patients without T2D. Materials and met
Externí odkaz:
https://doaj.org/article/e542d61f981246518d605deeea6397c7